Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 3
2013 2
2014 1
2015 3
2016 4
2018 1
2019 2
2020 2
2021 1
2022 2
2023 1
2024 1
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for maciuca r
Search for Vacirca R instead (1 results)
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.
Rovin BH, Furie R, Latinis K, Looney RJ, Fervenza FC, Sanchez-Guerrero J, Maciuca R, Zhang D, Garg JP, Brunetta P, Appel G; LUNAR Investigator Group. Rovin BH, et al. Among authors: maciuca r. Arthritis Rheum. 2012 Apr;64(4):1215-26. doi: 10.1002/art.34359. Epub 2012 Jan 9. Arthritis Rheum. 2012. PMID: 22231479 Clinical Trial.
LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease.
Jennings D, Huntwork-Rodriguez S, Vissers MFJM, Daryani VM, Diaz D, Goo MS, Chen JJ, Maciuca R, Fraser K, Mabrouk OS, van de Wetering de Rooij J, Heuberger JAAC, Groeneveld GJ, Borin MT, Cruz-Herranz A, Graham D, Scearce-Levie K, De Vicente J, Henry AG, Chin P, Ho C, Troyer MD. Jennings D, et al. Among authors: maciuca r. Mov Disord. 2023 Mar;38(3):386-398. doi: 10.1002/mds.29297. Epub 2023 Feb 18. Mov Disord. 2023. PMID: 36807624 Clinical Trial.
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease.
Jennings D, Huntwork-Rodriguez S, Henry AG, Sasaki JC, Meisner R, Diaz D, Solanoy H, Wang X, Negrou E, Bondar VV, Ghosh R, Maloney MT, Propson NE, Zhu Y, Maciuca RD, Harris L, Kay A, LeWitt P, King TA, Kern D, Ellenbogen A, Goodman I, Siderowf A, Aldred J, Omidvar O, Masoud ST, Davis SS, Arguello A, Estrada AA, de Vicente J, Sweeney ZK, Astarita G, Borin MT, Wong BK, Wong H, Nguyen H, Scearce-Levie K, Ho C, Troyer MD. Jennings D, et al. Among authors: maciuca rd. Sci Transl Med. 2022 Jun 8;14(648):eabj2658. doi: 10.1126/scitranslmed.abj2658. Epub 2022 Jun 8. Sci Transl Med. 2022. PMID: 35675433
LRRK2 kinase activity regulates Parkinson's disease-relevant lipids at the lysosome.
Maloney MT, Wang X, Ghosh R, Andrews SV, Maciuca R, Masoud ST, Agam M, Caprioli RM, Astarita G, Bondar VV, Chen J, Chiu CL, Davis SS, Ho AC, Nguyen HN, Propson NE, Reyzer ML, Davis OB, Deen MC, Zhu S, Di Paolo G, Vocadlo DJ, Estrada AA, de Vicente J, Lewcock JW, Arguello A, Suh JH, Huntwork-Rodriguez S, Henry AG. Maloney MT, et al. Among authors: maciuca r. Mol Neurodegener. 2025 Aug 6;20(1):89. doi: 10.1186/s13024-025-00880-7. Mol Neurodegener. 2025. PMID: 40770658 Free PMC article.
Investigational eIF2B activator DNL343 modulates the integrated stress response in preclinical models of TDP-43 pathology and individuals with ALS in a randomized clinical trial.
Flores BN, Yu SB, Cohen IV, Fanok MH, Luan W, Maciuca RD, Sun LD, Tsai RM, Vissers M, Smits L, Bunte TM, Bakardjiev A, Balasundar S, Calvert MEK, Chin MY, Dobbins SK, Dowdle WE, Fang M, Heuberger JAAC, Ha CL, Huang F, Miyamoto T, Osipov M, Madrid San Martin L, Saund K, Tatarakis D, Vu AQ, Xiong C, Yeo GW, Groeneveld GJ, van den Berg LH, Dhuria S, Estrada AA, Jennings D, Sandmann T, Ho C, Scearce-Levie K, Yulyaningsih E, Walker AK, Di Paolo G, Kane LA, Troyer MD, Lewcock JW. Flores BN, et al. Among authors: maciuca rd. Nat Commun. 2025 Aug 18;16(1):7690. doi: 10.1038/s41467-025-63031-y. Nat Commun. 2025. PMID: 40825784 Free PMC article. Clinical Trial.
DNL343 is an investigational CNS penetrant eukaryotic initiation factor 2B activator that prevents and reverses the effects of neurodegeneration caused by the integrated stress response.
Yulyaningsih E, Suh JH, Fanok M, Chau R, Solanoy H, Takahashi R, Bakardjiev AI, Becerra I, Benitez NB, Chiu CL, Davis SS, Dowdle WE, Earr T, Estrada AA, Gill A, Ha C, Haddick PCG, Henne KR, Larhammar M, Leung AW, Maciuca R, Memarzadeh B, Nguyen HN, Nugent AA, Osipov M, Ran Y, Rebadulla K, Roche E, Sandmann T, Wang J, Lewcock JW, Scearce-Levie K, Kane LA, Sanchez PE. Yulyaningsih E, et al. Among authors: maciuca r. Elife. 2024 Sep 17;12:RP92173. doi: 10.7554/eLife.92173. Elife. 2024. PMID: 39287504 Free PMC article.
Microbial Contamination and Survival Rate on Different Types of Banknotes.
Cozorici D, Măciucă RA, Stancu C, Tihăuan BM, Uță RB, Codrea CI, Matache R, Pop CE, Wolff R, Fendrihan S. Cozorici D, et al. Among authors: maciuca ra. Int J Environ Res Public Health. 2022 Apr 4;19(7):4310. doi: 10.3390/ijerph19074310. Int J Environ Res Public Health. 2022. PMID: 35409990 Free PMC article.
Peripheral blood gene expression predicts clinical benefit from anti-IL-13 in asthma.
Choy DF, Jia G, Abbas AR, Morshead KB, Lewin-Koh N, Dua R, Rivera P, Moonsamy P, Fontecha M, Balasubramanyam A, Santini C, Bassett E, Ray JM, Cabanski CR, Bradley MS, Maciuca R, Mosesova S, Scheerens H, Arron JR. Choy DF, et al. Among authors: maciuca r. J Allergy Clin Immunol. 2016 Oct;138(4):1230-1233.e8. doi: 10.1016/j.jaci.2016.06.008. Epub 2016 Jun 29. J Allergy Clin Immunol. 2016. PMID: 27474124 No abstract available.
22 results